Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Bioinformatics

Bioinformatics plays a crucial role in advancing NIST's mission by computationally analyzing large amounts of complex biological data generated by NIST and its collaborators. NIST provides benchmarks for the computational tools and methodologies necessary for conducting such work. Omics (genomic, proteomic, metabolomic, metagenomic, and transcriptomic) data, generated both inside and outside of NIST, NIST’s reference materials, benchmark datasets, and metadata standards underpin biological research and innovation. These standards help ensure the accuracy and reliability of large-scale biological measurements, which is essential for fields such as engineering biology, precision medicine, biotechnology, and public health.  

The NIST-hosted Genome in a Bottle Consortium has developed authoritatively characterized human genome reference materials. As the first RMs to be characterized for billions of properties, these have been used to train and test AI-based models and other bioinformatics tools. Similarly, the NIST Genome Editing Program, including the public-private partnership NIST Genome Editing Consortium, is developing benchmark samples, control datasets, and metadata norms, and conducting interlaboratory studies to qualify bioinformatics tools and approaches used to detect intended and unintended genome edits which is essential information for clinical applications.  

Further work in this area includes onboarding and deploying systematic approaches to add confidence to computational pipelines and their outputs for measurements used to identify where genome editing technologies may have made unintended (off-target) changes in a genome. NIST’s Microbial Metrology Program develops advanced measurements, reference materials, and standards for microbial systems to promote human health, precision medicine, advanced manufacturing, and other industrial applications. The Cellular Engineering Group is developing predictable and versatile RNA circuits, based on nucleic acid strand displacement reactions to meet emerging molecular computation and measurement needs in biological systems. The NIST Mass Spectrometry Data Center develops evaluated mass spectral libraries and provides related software tools. 

News and Updates

How Secure Is Your DNA?

Is genomic data distinct from other data types? How should cybersecurity protection be tailored to genomic data? NIST is working to find the answers.

Spotlight: For Bioinformaticist Sierra Miller, the Scientific Breakthrough Is Hidden in the Data

New NIST Method Can Better Identify Sneaky Sugars on Viruses’ Spiky Weapons

Upcoming Events

AI and Flow Cytometry Workshop

Mon, Jun 9 - Tue, Jun 10 2025
A NIST–FDA–NIAID Co-Organized Workshop This workshop aims to advance AI/ML applications in flow cytometry and related

Genome Editing Consortium Workshop

Thu, Jun 12 - Fri, Jun 13 2025
The purpose of this workshop is to share and obtain feedback on current and future activities of the NIST Genome Editing

The Research

Biosecurity for Synthetic Nucleic Acid Sequences

Ongoing
Synthetic nucleic acid technologies are fundamental to U.S. biotechnology and biomanufacturing innovation. However, like other transformative technologies, they carry dual-use potential: while they can drive significant progress, they pose risks of unintentional or deliberate misuse to engineer

Biosurveillance and Pathogen Detection

Ongoing
NIST has established partnerships with other federal agencies to develop standards and measurement solutions to support biosurveillance. These efforts are supported in part through interagency agreements with partner agencies listed below to address their standards needs. PROGRAMS Standards for

Cancer Biomarker Measurements and Collaborations

Ongoing
Collaborations and Cooperative Research Agreements We welcome collaborations and can help with assay validation and development of reference materials. Below are some examples of our collaborations and ways we can develop test materials. Early Detection Research Network (EDRN): Interagency agreement

Cancer Genome in a Bottle

Ongoing
Goals: This project is an extension of the Genome in a Bottle Consortium to develop the technical infrastructure (reference standards, reference methods, and reference data) to enable translation of cancer genome sequencing to clinical practice and innovations in technologies. The priority of GIAB
Was this page helpful?